AzTrials
AzTrials

Mood DisordersOASNCT04137471

Validation of the Ontological Addiction Scale

An observational study of Mood Disorders and Emotional Disorder, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Bypassing a reductionist view of existing diagnostic categories, ontological addiction theory (OAT) is a new psychological model of human functioning and mental illness. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Mood Disorders, Emotional Disorder
How many people
400 participants
Where
1 siteFrance
Study dates
1 Nov 2019to 31 Mar 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Individual suffering from mood disorder (bipolar or unipolar) and/or emotional disorder (subjective complaint for difficulties to regulate emotions).

Who may be able to join

  • An individual must fulfill all of the following criteria in order to be eligible for study enrollment:
  • Aged between 18 and 70 years
  • Suffering from mood disorder (bipolar or unipolar) and/or emotional disorder (subjective complaint for difficulties to regulate emotions).
  • Being referred to the Therapeutic Center for Mood and Emotional Disorders for an 8-week-mindfulness-based-intervention
  • Subjects must be able to attend all scheduled visits and to comply with all trial procedures
  • Subjects must be covered by public health insurance

Who cannot join

  • Subject unable to read or/and write
  • Psychosis
  • Subject who are in a dependency or employment with the sponsor or the investigator

Trial locations and contacts

1 site in 1 country.

France1 site
  • Uh Montpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Ontological Addiction Scale: Study Protocol for Scale Validation

Background:

Bypassing a reductionist view of existing diagnostic categories, ontological addiction theory (OAT) is a new psychological model of human functioning and mental illness. Ontological addiction is a maladaptive condition that stems from an erroneous belief in an inherently existing Self or "I", which is deemed to be the root of all suffering. Five experts from four different countries have created the Ontological Addiction Scale (OAS) to measure the condition and its impact on people's lives. The purpose of this study is to test this scale, evaluating levels of ontological addiction in individuals suffering from emotional or mood disorder, and assess its psychometric properties.

Read more

Methods:

This trial will be conducted in compliance with the COSMIN Guidelines. The investigators will collect data from 400 individuals, aged 18 to 70, suffering from emotional or mood disorder, referred to the Therapeutic Center for Mood and Emotional Disorders for an 8-week-mindfulness-based-intervention. Patients will complete the OAS at three time points: one month before the beginning of the therapy, within one week prior to the beginning of therapy, and one year after the end of the therapy. This scale will be completed in conjunction with other practice assessments relating to the psychotherapeutic program. The psychometric properties of the OAS will be assessed.

Discussion:

The Investigators aim to validate a scale assessing a psychological dimension as the root of all mental disorders. The present study may contribute to overcoming limitations of categorical understanding of mental disorders, thus moving toward a more encompassing dimensional comprehension. The scale is responsive to current thinking in modern psychiatry, and it is envisaged that its validation will deeply impact research and care perspectives

Medical subject headings
Mood Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Validation of the Ontological Addiction Scale by measurement of its psychometric properties

    Evaluation of the structural validity of the Ontological Addiction Scale (OAS)

    Measured: one year after the end of the therapy

Secondary outcomes (18)
  1. Measurement of the structural validity of the Ontological Addiction Scale by means of factor analysis (the technique of rotation of the main axes varimax will be used)

    Evaluation of the structural validity of the Ontological Addiction Scale (OAS)

    Measured: pre-treatment (first assessment) within one week prior to the beginning of therapy

  2. Measurement of internal consistency of the Ontological Addiction Scale by a multitrait analysis (assessment of redundancy between items, validation of item consistency, assessment of item dimension intercorrelations)

    Evaluation of internal consistency of the Ontological Addiction Scale (OAS)

    Measured: pre-treatment (first assessment) within one week prior to the beginning of therapy

  3. Measurement of reliability of the Ontological Addiction Scale by test-retest (degree to which the measurement is free from measurement error)

    Evaluation of reliability of the Ontological Addiction Scale (OAS)

    Measured: pre-treatment (first assessment) within one week prior to the beginning of therapy

  4. Error measurement of the Ontological Addiction Scale by the calculation of the Strandard Error of the Mean.

    Measurment error of the Ontological Addiction Scale (OAS)

    Measured: pre-treatment (first assessment) within one week prior to the beginning of therapy

  5. Content validity measurement of the Ontological Addiction Scale

    Content validity measurement of the Addiction Scale (OAS) by content validity index (assessment of the simplicity and clarity of the questionnaire on a 4-point likert scale from not relevant to highly relevant. The answers will then be dichotomized as "not relevant" (score 1 or 2) or "relevant" (score 3 or 4)).

    Measured: pre-treatment (first assessment) within one week prior to the beginning of therapy

  6. Levels of concern about the mental representation that patients have of themselves (ontological addiction) by the Ontological Addiction Scale (by responding either "never", "rarely", "sometimes", "often", "always" to the 24 items)

    Evaluation of ontological addiction by the ontological addiction scale

    Measured: pre-treatment (first assessment) within one week prior to the beginning of therapy

  7. Measurement of the structural validity of the Ontological Addiction Scale by means of factor analysis (the technique of rotation of the main axes varimax will be used)

    Evaluation of the structural validity of the Ontological Addiction Scale (OAS)

    Measured: post therapy (second assessment) within the week following completion of therapy

  8. Measurement of internal consistency of the Ontological Addiction Scale by a multitrait analysis (assessment of redundancy between items, validation of item consistency, assessment of item dimension intercorrelations)

    Evaluation of internal consistency of the Ontological Addiction Scale (OAS)

    Measured: post therapy (second assessment) within the week following completion of therapy

  9. Measurement of reliability of the Ontological Addiction Scale by test-retest (degree to which the measurement is free from measurement error)

    Evaluation of reliability of the Ontological Addiction Scale (OAS)

    Measured: post therapy (second assessment) within the week following completion of therapy

  10. Error measurement of the Ontological Addiction Scale by the calculation of the Strandard Error of the Mean

    Measurment error of the Ontological Addiction Scale (OAS)

    Measured: post therapy (second assessment) within the week following completion of therapy

  11. Content validity measurement of the Ontological Addiction Scale

    Content validity measurement of the Addiction Scale (OAS) by content validity index (assessment of the simplicity and clarity of the questionnaire on a 4-point likert scale from not relevant to highly relevant). The answers will then be dichotomized as "not relevant" (score 1 or 2) or "relevant" (score 3 or 4)).

    Measured: post therapy (second assessment) within the week following completion of therapy

  12. Levels of concern about the mental representation that patients have of themselves (ontological addiction) by the Ontological Addiction Scale (by responding either "never", "rarely", "sometimes", "often", "always" to the 24 items)

    Evaluation of ontological addiction by the ontological addiction scale

    Measured: post therapy (second assessment) within the week following completion of therapy

  13. Measurement of the structural validity of the Ontological Addiction Scale by means of factor analysis (the technique of rotation of the main axes varimax will be used)

    Evaluation of the structural validity of the Ontological Addiction Scale (OAS)

    Measured: one year after the end of the therapy.

  14. Measurement of internal consistency of the Ontological Addiction Scale by a multitrait analysis (assessment of redundancy between items, validation of item consistency, assessment of item dimension intercorrelations)

    one year after the end of the therapy.

    Measured: Evaluation of internal consistency of the Ontological Addiction Scale (OAS)

  15. Measurement of reliability of the Ontological Addiction Scale by test-retest (degree to which the measurement is free from measurement error)

    Evaluation of reliability of the Ontological Addiction Scale (OAS)

    Measured: one year after the end of the therapy.

  16. Error measurement of the Ontological Addiction Scale by the calculation of the Strandard Error of the Mean

    Measurment error of the Ontological Addiction Scale (OAS)

    Measured: one year after the end of the therapy.

  17. Content validity measurement of the Ontological Addiction Scale

    Content validity measurement of the Addiction Scale (OAS) by content validity index (assessment of the simplicity and clarity of the questionnaire on a 4-point likert scale from not relevant to highly relevant). The answers will then be dichotomized as "not relevant" (score 1 or 2) or "relevant" (score 3 or 4)).

    Measured: one year after the end of the therapy.

  18. Levels of concern about the mental representation that patients have of themselves (ontological addiction) by the Ontological Addiction Scale (by responding either "never", "rarely", "sometimes", "often", "always" to the 24 items)

    Evaluation of ontological addiction by the ontological addiction scale

    Measured: one year after the end of the therapy.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2019
  2. Study start1 Nov 2019
  3. Primary completion1 Mar 2021
  4. Study completion31 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04137471
Sponsor's protocol ID
RECHMPL19_0466
Acronym
OAS
Status last verified
Oct 2021
First submitted
30 Sep 2019
Last updated
25 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Publications

  • Ducasse D, Leurent M, Picot MC, Aouinti S, Brand-Arpon V, Courtet P, Barrows P, Shonin E, Sapthiang S, Olie E, Van Gordon W. French Translation and Validation of the Ontological Addiction Scale (OAS). Int J Environ Res Public Health. 2025 Mar 27;22(4):511. doi: 10.3390/ijerph22040511.

    PubMed 40283737

Questions about this trial

What is this clinical trial studying?

An observational study of Mood Disorders and Emotional Disorder, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Validation of the Ontological Addiction Scale by measurement of its psychometric properties (time frame: one year after the end of the therapy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04137471, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2021; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in